Filing Details
- Accession Number:
- 0001209191-22-062643
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-23 17:03:07
- Reporting Period:
- 2022-11-01
- Accepted Time:
- 2022-12-23 17:03:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-01 | 65 | $2.53 | 54,506 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-02 | 65 | $2.54 | 54,571 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-03 | 65 | $2.44 | 54,636 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-04 | 65 | $2.42 | 54,701 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-07 | 65 | $2.45 | 54,766 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-08 | 65 | $2.42 | 54,831 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-09 | 65 | $2.37 | 54,896 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-10 | 65 | $2.37 | 54,961 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-11 | 65 | $2.32 | 55,026 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-14 | 65 | $2.32 | 55,091 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-15 | 65 | $2.35 | 55,156 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-16 | 65 | $2.31 | 55,221 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-17 | 65 | $2.29 | 55,286 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-18 | 65 | $2.27 | 55,351 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-21 | 65 | $2.38 | 55,416 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-22 | 65 | $2.37 | 55,481 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-23 | 65 | $2.29 | 55,546 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-25 | 65 | $2.31 | 55,611 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-28 | 65 | $2.37 | 55,676 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-29 | 65 | $2.34 | 55,741 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-11-30 | 65 | $2.32 | 55,806 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
